Effect of propofol on proliferation of human liver cancer cell line HepG2
10.3760/cma.j.issn.0254-1416.2012.10.006
- VernacularTitle:异丙酚对人肝癌HepG2细胞增殖的影响
- Author:
Qiaoling ZHOU
;
Miaoning GU
;
Chengxiang YANG
;
Hua LIANG
;
Yi LIU
;
Xiaohong LAI
;
Hongzhen LIU
;
Hanbing WANG
;
Shu CHEN
- Publication Type:Journal Article
- Keywords:
Propofol;
Cell line,tumor;
Cell proliferation
- From:
Chinese Journal of Anesthesiology
2012;(10):1182-1185
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the effect of propofol on proliferation of human liver cancer cell line HepG2.Methods HepG2 cells were seeded in 96-well plates (100μl/hole) with a density of 1 × 105/ml and randomly divided into 5 groups (n =33 each)∶ control group (group C),group intralipid (group Ⅰ),and propofol 30,60 and 120μg/ml groups (groups P1-3).In groups P1-3,propofol 30,60 and 120 μg/ml were added to the culture medium and then the cells were cultured for 72 h.In group Ⅰ,10% intralipid was added to the culture medium and then the cells were cultured for 72 h.The morphology of cells was observed with the light microscope after 24 h of incubation with propofol.The proliferation of the cells was determined at 0,24,48 and 72 h of incubation with propofol.The expression of Fas was determined at 48 h of incubation with propofol.Results The number of the cells was gradually smaller in groups P1-3.The proliferation of the cells was significantly higher in group Ⅰ,while lower in groups P1-3 than in group C (P < 0.05).There was no significant difference in the expression of Fas between group Ⅰ and group C (P > 0.05).The expression of Fas was significantly higher in groups P1-3 than in group C (P < 0.05).The proliferation of the cells was significantly lower,and the expression of Fas was significantly higher in group P3 than in group P1 or group P2 (P < 0.05).Conclusion Propofol can inhibit the proliferation of human liver cancer cell line HepG2 in a concentration-dependent manner and up-regulation of the expression of Fas is involved in the mechanism.